Back

Left ventricular septal pacing as a single ventricular lead approach to cardiac resynchronization therapy: acute hemodynamic and electrophysiological effects

18 March 2019 (17:20 - 17:30)
Organised by:
Congress Presentation Part of: Rapid Fire 5: improving the response to cardiac resynchronization therapy: emerging technologies Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2019

About the speaker

Photo
Ms Fcwm Salden

Maastricht University Medical Center+, Maastricht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Survival after cardiac resynchronization therapy: results from 50,084 implantations
Professor F. Leyva (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Electrical activation versus mechanical contraction in cardiac resynchronization therapy recipients:comparison between electroanatomical mapping and feature-tracking cardiovascular magnetic resonance
Doctor O. Okafor (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Italian multicenter experience with a new active fixation quadripolar left ventricular lead
Doctor M. Ziacchi (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Acute electrical and hemodynamic effects of CRT pacing using a micro-catheter guided LV lead in the preclinical setting - the Axone European project.
Mr L. Heckman (Maastricht, NL)
Abstract
Presentation thumbnail
Long term experience of the efficacy and safety of the transseptal endocardial left ventricular lead implantation - An alternative technique in cases of failed cardiac resynchronization therapy
Professor L. Geller (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Rapid Fire 5: improving the response to cardiac resynchronization therapy: emerging technologies

The Event

Event poster

EHRA 2019

18 March 2019 17:20 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Conduction system pacing in challenging settings

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources